FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Laurus Labs LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:540222 NSE Symbol: LAURUSLABS P/E (TTM) :107.78
ISIN Demat:INE947Q01028 Div & Yield %:0.09 EPS (TTM) :4.15
Book Value (RS) :78.057879 Market Cap (Rs Cr.):24107.94 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Mar 2024)		 Quarter Ended
(Mar 2023)		 Quarter Ended
(% Var)
Sales 1,414.52 1,279.34 10.57
Other Income 24.09 5.94 305.56
PBIDT 295.20 258.38 14.25
Interest 41.99 41.03 2.34
PBDT 253.21 217.35 16.50
Depreciation 88.90 80.55 10.37
PBT 164.31 136.80 20.11
Tax 45.94 7.44 517.47
Deferred Tax -2.95 27.08 -110.89
PAT 121.32 102.28 18.62

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)